Clinical Trial Update: Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is recruiting for CXCR5-modified EGFR-targeted CAR-T cells to treat advanced non-small cell lung cancer, sponsored by the Second…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CXCR5 Modified EGFR Targeted CAR-T Cells

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Non Small Cell Lung Cancer | EARLY_Phase 1 | Status: RECRUITING